Module 5000: Bacterial Antigens for meningitis Qualitative Statistics Summary

Transcription

1 Module 5000: Bacterial Antigens for meningitis Qualitative Statistics Summary H influenzae type b antigen BA 6 BA 7 BA 8 BA 9 BA 10 BD Directigen * Positive % * Negative % * Negative % * Negative % * Negative % All Methods * Positive % * Negative % * Negative % * Negative % * Negative % N. meningitidis A/C/Y/W135 BA 6 BA 7 BA 8 BA 9 BA 10 BD Directigen * Negative % * Negative % * Negative % * Group A/Y % * Negative % Negative % All Methods * Negative % * Negative % * Negative % * Group A/Y % * Negative % * Positive % Negative % N. meningitidis B / E. coli K1 BA 6 BA 7 BA 8 BA 9 BA 10 BD Directigen * Negative % * Negative % * Negative % * Negative % Positive % All Methods * Negative % * Negative % * Negative % * Negative % Positive % S. pneumoniae antigen BA 6 BA 7 BA 8 BA 9 BA 10 BD Directigen * Negative % * Positive % * Negative % * Negative % * Negative % Negative % All Methods * Negative % * Positive % * Negative % * Negative % * Negative % Negative % Strep Grp B antigen BA 6 BA 7 BA 8 BA 9 BA 10 BD Directigen * Negative % * Negative % * Positive % * Negative % * Negative % All Methods * Negative % * Negative % * Positive % * Negative % * Negative % *Denotes correct response

2 Modules 5030 and 5040: Comprehensive Bacteriology and Bacteriology Limited Scoring Group Result N % Strep Group A antigen waived MC 10 Quidel QuickVue * Negative % All methods * Negative % Strep Group A antigen MC 10 Quidel QuickVue+ * Negative % All methods * Negative % Strep Group A culture MC 11 Bacitracin * Positive % Blood agar * Positive % All Methods Group * Positive % Negative % N. gonorrhoeae culture MC 12 Remel RapID NH Panel * Positive % Modified Thayer Martin media * Positive % All Methods Group * Positive % * Gram negative diplococci 22 present would refer 34.92% Negative % C. difficile antigen MC 15 TECHLAB C. DIFF QUIK CHEK COMPLETE * Positive % All Methods Group * Positive % C. difficile toxin MC 15 Cepheid GeneXpert * Positive % TECHLAB C. DIFF QUIK CHEK COMPLETE * Positive % Meridian illumigene * Positive % All Methods Group * Positive %

3 MRSA ID MC 16 Cepheid GeneXpert * Positive % Negative % Spectra MRSA * Positive % All Methods Group * Positive % Negative % VRE ID MC 16 biomerieux Vitek 2 * Negative % Siemens Inc. Microscan * Negative % Conventional agar plates * Negative % All Methods Group * Negative % Strep Grp B Culture MC 17 All Methods Group * Positive % * Denotes Correct Response

4 Module 5060: C. difficile Qualitative Statistics Summary C. difficile toxin CD 6 CD 7 CD 8 CD 9 CD 10 Cepheid Genexpert * Negative % * Positive % * Positive % * Negative % * Negative % Negative % TECHLAB C. DIFF QUIK CHEK COMPLETE * Negative % * Positive % * Positive % * Negative % * Negative % All Methods * Negative % * Positive % * Positive % * Negative % * Negative % Positive % Negative % Negative % C. difficile antigen CD 6 CD 7 CD 8 CD 9 CD 10 TECHLAB C. DIFF QUIK CHEK COMPLETE * Negative % * Positive % * Positive % * Positive % * Negative % All Methods * Negative % * Positive % * Positive % * Positive % * Negative % * Denotes correct response

5 Module 5070: CT/GC Detection Qualitative Statistics Summary Chlamydia trachomatis AC 6 AC 7 AC 8 AC 9 AC 10 Cepheid GeneXpert * Positive % * Negative % * Negative % * Positive % * Negative % Gen probe APTIMA * Positive % * Negative % * Negative % * Positive % * Negative % All Methods * Positive % * Negative % * Negative % * Positive % * Negative % Negative % Negative % Neisseria gonorrhoeae AC 6 AC 7 AC 8 AC 9 AC 10 Cepheid GeneXpert * Positive % * Positive % * Positive % * Positive % * Negative % Negative % Gen Probe APTIMA * Positive % * Positive % * Positive % * Positive % * Negative % All Methods * Positive % * Positive % * Positive % * Positive % * Negative % Negative % * Denotes correct response

6 Module 5110: Group A Strep Antigen Qualitative Statistics Summary Strep Grp A antigen SA 6 SA 7 SA 8 SA 9 SA 10 Quidel QuickVue (Waived) * Positive % * Positive % * Negative % * Positive % * Negative % Quidel QuickVue+ (Non waived) * Positive % * Positive % * Negative % * Positive % * Negative % Negative % Positive % OSOM (Waived) * Positive % * Positive % * Negative % * Positive % * Negative % Quidel Quickvue group * Positive % * Positive % * Negative % * Positive % * Negative % All Methods * Positive % * Positive % * Negative % * Positive % * Negative % Negative % Positive % * Denotes correct response

7 Module 5170: Group A Strep Culture Qualitative Statistics Summary Strep Grp A culture ST 6 ST 7 ST 8 ST 9 ST 10 Blood agar * Negative % * Positive % * Positive % * Negative % * Positive % Positive % Selective Group A Strep Agar + Bacitracin disk Selective Strep A agar (w/ neomycin &polymyxin B * Negative % * Positive % * Positive % * Negative % * Positive % Negative % * Negative % * Positive % * Positive % * Negative % * Positive % Negative % Negative % Negative % All Methods * Negative % * Positive % * Positive % * Negative % * Positive % Positive % Negative % Negative % Positive % Negative % *Denotes correct response

8 Module 5180: Group B Strep Qualitative Statistics Summary Strep Grp B culture SB 6 SB 7 SB 8 SB 9 SB 10 Cepheid Genexpert * Positive % * Negative % * Positive % * Negative % * Positive % All Methods * Positive % * Negative % * Positive % * Negative % * Positive % * Denotes correct response

9 Module 5200: MRSA/VRE Qualitative Statistics Summary MRSA ID MR 6 MR 7 MR 8 MR 9 MR 10 Cepheid GeneXpert * Positive % * Positive % * Negative % * Positive % * Negative % Negative % Negative % Spectra MRSA * Positive % * Positive % * Negative % * Positive % * Negative % All Methods * Positive % * Positive % * Negative % * Positive % * Negative % Negative % Negative % Positive % VRE ID MR 6 MR 7 MR 8 MR 9 MR 10 biomerieux Vitek 2 * Negative % * Positive % * Positive % * Positive % * Negative % All Methods * Negative % * Positive % * Positive % * Positive % * Negative % Negative % Negative % *Denotes correct response

10 Module 5220: Neisseria gonorrhoeae Qualitative Statistics Summary N. gonorrhoeae culture GC 6 GC 7 GC 8 GC 9 GC 10 All Methods Negative % Negative % Negative % Positive % Positive %

11 Modules 5250 and 5260: Throat/Urine Bacteriology Qualitative Statistics Scoring Group Result N % Result N % Strep Group A culture TU 11 TU 12 Selective Group A Strep agar + Bacitracin disk * Negative % * Positive % All Methods Group * Negative % * Positive % Strep Group A antigen TU 13 TU 14 All methods * Negative % * Negative % * Denotes Correct Response

12 Module 5280: Vaginal Pathogens Qualitative Statistics Summary Gardnerella VP 6 VP 7 VP 8 VP 9 VP 10 Affirm VP III * Positive % * Positive % * Positive % * Negative % * Negative % Negative % Negative % Negative % Trichomonas VP 6 VP 7 VP 8 VP 9 VP 10 Affirm VP III * Negative % * Negative % * Positive % * Negative % * Negative % OSOM * Negative % * Negative % * Positive % * Negative % * Negative % Negative % Positive % All Methods * Negative % * Negative % * Positive % * Negative % * Negative % Negative % Positive % Candida Species VP 6 VP 7 VP 8 VP 9 VP 10 Affirm VP III * Positive % * Negative % * Positive % * Positive % * Negative % Negative % * Denotes correct response

13 2015 BactiReg2 Samples: MC 14, TU 10, UC 10 WSLH Proficiency Testing Antimicrobial Susceptibility Testing Results Summary Antibiotic Interpretation N % MIC or zone size N 1 of 5 Amikacin Susceptible <= 2 ug/ml 8 <=16 ug/ml 18 Amoxicillin/Clavulanate Susceptible <= 2 ug/ml 11 <=4/2 ug/ml 2 <=8/4 ug/ml mm 1 20 mm 1 21 mm 1 * Intermediate 1 3 * 16/8 ug/ml 1 Ampicillin Susceptible <=2 ug/ml 16 <=4 ug/ml 2 <=8 ug/ml 29 4 ug/ml mm 1 20 mm 1 21 mm 1 23 mm 1 * Intermediate 2 3 * 16 mm 1 Ampicillin/Sulbactam Susceptible <=0.06 ug/ml 1 <=2 ug/ml 25 <=8/4 ug/ml 23 4/2 ug/ml 1 Aztreonam Susceptible <=1 ug/ml 4 <=2 ug/ml 1 <=4 ug/ml 12 * <=8 ug/ml 3 Cefazolin Susceptible <=1 ug/ml 1 <=2 ug/ml 9 <=4 ug/ml 26 <=8 ug/ml mm 1 25 mm 1 * Intermediate 1 2 * 22 mm 1 * Unsatisfactory Result N Not Scored I Inappropriate

14 2015 BactiReg2 Samples: MC 14, TU 10, UC 10 WSLH Proficiency Testing Antimicrobial Susceptibility Testing Results Summary Antibiotic Interpretation N % MIC or zone size N 2 of 5 N Cefdinir Susceptible mm 1 Cefepime Susceptible <=1 ug/ml 25 <=2 ug/ml 2 N <=4 ug/ml 7 N <=8 ug/ml 4 N Cefixime Susceptible mm 1 Cefotaxime Susceptible <=1 ug/ml 4 * <=2 ug/ml 7 N Cefotetan Susceptible <=16 ug/ml 1 <=4 ug/ml 1 Cefoxitin Susceptible <=4 ug/ml 14 <=8 ug/ml 6 * >=8 ug/ml 1 Ceftazidime Susceptible <=1 ug/ml 32 <=4 ug/ml 1 Ceftriaxone Susceptible <=1 ug/ml 35 * <=8 ug/ml 4 24 mm 1 30 mm 1 Cefuroxime axetil (oral) Susceptible <=4 ug/ml 13 4 ug/ml 1 23 mm 1 N Cefuroxime sodium (parenteral) Susceptible <=4 ug/ml 5 N Cephalothin Susceptible ug/ml 1 Intermediate ug/ml 1 Resistant mm 1 * Unsatisfactory Result N Not Scored I Inappropriate

15 2015 BactiReg2 Samples: MC 14, TU 10, UC 10 WSLH Proficiency Testing Antimicrobial Susceptibility Testing Results Summary Antibiotic Interpretation N % MIC or zone size N 3 of 5 Ciprofloxacin Susceptible <=0.06 ug/ml 1 <=0.25 ug/ml 30 <=0.5 ug/ml 1 <=1 ug/ml mm 1 32 mm 2 35 mm 1 36 mm 2 N Doripenem Susceptible <=0.12 ug/ml 1 <=0.5 ug/ml 2 Ertapenem Susceptible <=0.5 ug/ml 20 * <=1 ug/ml 2 * <=2 ug/ml 4 N Fosfomycin Susceptible mm 1 Gentamicin Susceptible <=1 ug/ml 33 <=2 ug/ml 5 <=4 ug/ml mm 1 21 mm 1 23 mm 1 24 mm 1 I Gentamicin synergy screen * Susceptible * <=1 ug/ml 1 Imipenem Susceptible <=0.25 ug/ml 14 <=1 ug/ml 17 * <=4 ug/ml 1 27 mm 1 Levofloxacin Susceptible <=0.12 ug/ml 24 <=1 ug/ml 2 <=2 ug/ml mm 1 34 mm 1 * Unsatisfactory Result N Not Scored I Inappropriate

16 2015 BactiReg2 Samples: MC 14, TU 10, UC 10 WSLH Proficiency Testing Antimicrobial Susceptibility Testing Results Summary Antibiotic Interpretation N % MIC or zone size N 4 of 5 Meropenem Susceptible <=0.25 ug/ml 8 <=1 ug/ml 12 * <=4 ug/ml 1 Minocycline Susceptible N Moxifloxacin Susceptible <=2 ug/ml 1 Nitrofurantoin Susceptible <=16 ug/ml 27 <=32 ug/ml ug/ml 5 17 mm 2 18 mm 1 19 mm 1 24 mm 2 N Norfloxacin Susceptible <=0.5 ug/ml 1 N Piperacillin Susceptible <=4 ug/ml 2 <=16 ug/ml 1 26 mm 1 Piperacillin/Tazobactam Susceptible <=2/4 ug/ml 1 <=4 ug/ml 20 <=8 ug/ml 1 <=16/4 ug/ml 1 <=16 ug/ml 22 Tetracycline Susceptible <=1 ug/ml 3 <=2 ug/ml 1 <=4 ug/ml mm 1 N Ticarcillin/Clavulanate Susceptible <=16 ug/ml 8 <= 16/2 ug/ml 1 N Tigecycline Susceptible <=0.5 ug/ml 1 <=2 ug/ml 2 Tobramycin Susceptible <=1 ug/ml 20 <=2 ug/ml 2 <=4 ug/ml 19 2 ug/ml 1 * Unsatisfactory Result N Not Scored I Inappropriate

17 2015 BactiReg2 Samples: MC 14, TU 10, UC 10 WSLH Proficiency Testing Antimicrobial Susceptibility Testing Results Summary Antibiotic Interpretation N % MIC or zone size N 5 of 5 N Trimethoprim Susceptible <=8 ug/ml 2 26 mm 2 Trimethoprim/Sulfamethoxazole Susceptible <=0.5/9.5 ug/ml 2 <=20 (1/19) ug/ml 33 <=2/38 ug/ml mm 1 26 mm 1 27 mm 1 32 mm 1 * Resistant 1 1 * Unsatisfactory Result N Not Scored I Inappropriate